|
🐜
|
The ICD‐11 developmental field study of reliability of diagnoses of high‐burden mental disorders: results among adult patients in mental health settings of 13 countries
45 auth.
G. Reed,
P. Sharan,
T. Rebello,
J. Keeley,
María Elena Medina‐Mora,
O. Gureje,
José Luís Ayuso-Mateos,
S. Kanba,
B. Khoury,
C. Kogan,
V. Krasnov,
M. Maj,
J. de Jesus Mari,
D. Stein,
Min Zhao,
...
T. Akiyama,
H. Andrews,
E. Asevedo,
M. Cheour,
Tecelli Domínguez-Martínez,
J. El-Khoury,
A. Fiorillo,
J. Grenier,
N. Gupta,
Lola Kola,
M. Kulygina,
I. Leal‐Leturia,
M. Luciano,
Bulumko Lusu,
J. Nicolas,
I. Martínez-López,
C. Matsumoto,
Lucky E. Umukoro Onofa,
S. Paterniti,
S. Purnima,
Rebeca Robles,
M. Sahu,
G. Sibeko,
Na Zhong,
M. First,
W. Gaebel,
A. Lovell,
T. Maruta,
Michael C. Roberts,
K. Pike
|
6 |
2018 |
6
🐜
|
|
🦁
|
Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
13 auth.
E. Asevedo,
A. Gadelha,
Cristiano Noto,
R. Mansur,
A. Zugman,
S. Belangero,
A. Berberian,
B. S. Scarpato,
Emilie Leclerc,
A. Teixeira,
...
C. Gama,
R. Bressan,
E. Brietzke
|
6 |
2013 |
6
🦁
|
|
🦁
|
Systematic review of N-acetylcysteine in the treatment of addictions.
E. Asevedo,
A. Mendes,
M. Berk,
E. Brietzke
|
6 |
2014 |
6
🦁
|
|
🐜
|
Clinical utility of ICD‐11 diagnostic guidelines for high‐burden mental disorders: results from mental health settings in 13 countries
45 auth.
G. Reed,
J. Keeley,
T. Rebello,
M. First,
O. Gureje,
J. Ayuso-Mateos,
S. Kanba,
B. Khoury,
C. Kogan,
V. Krasnov,
M. Maj,
Jair de Jesus Mari,
P. Sharan,
Dan J Stein,
Min Zhao,
...
T. Akiyama,
H. Andrews,
E. Asevedo,
M. Cheour,
Tecelli Domínguez-Martínez,
J. El-Khoury,
A. Fiorillo,
J. Grenier,
N. Gupta,
Lola Kola,
M. Kulygina,
I. Leal‐Leturia,
M. Luciano,
Bulumko Lusu,
J. Martínez-López,
C. Matsumoto,
Mayokun Odunleye,
L. Onofa,
S. Paterniti,
S. Purnima,
Rebeca Robles,
M. Sahu,
G. Sibeko,
Na Zhong,
W. Gaebel,
A. Lovell,
T. Maruta,
K. Pike,
Michael C. Roberts,
M. Medina-Mora
|
6 |
2018 |
6
🐜
|
|
🐜
|
Abnormalities in sleep patterns in individuals at risk for psychosis and bipolar disorder
11 auth.
M. Zanini,
J. Castro,
G. Cunha,
E. Asevedo,
P. Pan,
L. Bittencourt,
...
F. Coelho,
S. Tufik,
A. Gadelha,
R. Bressan,
E. Brietzke
|
5 |
2015 |
5
🐜
|
|
🦁
|
Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia
10 auth.
E. Asevedo,
L. Rizzo,
A. Gadelha,
R. Mansur,
V. Ota,
A. Berberian,
...
B. S. Scarpato,
A. Teixeira,
R. Bressan,
E. Brietzke
|
5 |
2014 |
5
🦁
|
|
🐬
|
Cytokines in schizophrenia: Possible role of anti‐inflammatory medications in clinical and preclinical stages
R. Mansur,
A. Zugman,
E. Asevedo,
Graccielle Rodrigues da Cunha,
R. Bressan,
E. Brietzke
|
5 |
2012 |
5
🐬
|
|
🐜
|
Dysregulated Lipid Metabolism Precedes Onset of Psychosis
69 auth.
A. Dickens,
Partho Sen,
M. Kempton,
N. Barrantes-Vidal,
C. Iyegbe,
M. Nordentoft,
T. Pollak,
A. Riecher-Rössler,
S. Ruhrmann,
G. Sachs,
R. Bressan,
M. Krebs,
G. Amminger,
L. de Haan,
M. van der Gaag,
...
L. Valmaggia,
T. Hyötyläinen,
M. Orešič,
P. McGuire,
L. Valmaggia,
Maria Calem,
S. Tognin,
G. Modinos,
M. van der Gaag,
E. Velthorst,
T. Kraan,
D. V. van Dam,
Nadine Burger,
B. Nelson,
P. McGorry,
C. Pantelis,
Athena Politis,
J. Goodall,
S. Borgwardt,
C. Rapp,
S. Ittig,
E. Studerus,
R. Smieskova,
A. Gadelha,
E. Brietzke,
G. Asevedo,
E. Asevedo,
A. Zugman,
N. Barrantes-Vidal,
Tecelli Domínguez-Martínez,
Anna Racciopi,
T. Kwapil,
Manel Monsonet,
A. Rosa,
A. Frajerman,
B. Chaumette,
J. Bourgin,
O. Kebir,
Célia Jantac,
D. Nordholm,
L. Randers,
K. Krakauer,
L. Glenthøj,
B. Glenthøj,
S. Ruhrmann,
Dominika Gebhard,
Julia Arnhold,
J. Klosterkötter,
G. Sachs,
I. Lasser,
B. Winklbaur,
P. Delespaul,
B. Rutten,
J. van os
|
5 |
2020 |
5
🐜
|
|
🐜
|
The association between adolescent suicide rates and socioeconomic indicators in Brazil: a 10-year retrospective ecological study
7 auth.
Denisse Jaen-Varas,
J. Mari,
E. Asevedo,
R. Borschmann,
E. Diniz,
C. Ziebold,
...
A. Gadelha
|
5 |
2019 |
5
🐜
|
